David A. Haggstrom, MD, MAS
Associate Professor of Medicine, Indiana University School of Medicine
Research Scientist, Indiana University Center for Health Services and Outcomes Research
Research Scientist, William M. Tierney Center for Health Services Research, Regenstrief Institute, Inc.
Core Investigator, VA HSR&D Center for Health Information and Communication
Associate Member, Melvin and Bren Simon Indiana University Cancer Center
Co-Leader, Cancer Prevention and Control Program
Dr. Haggstrom is a general internist, attending staff physician in Richard L. Roudebush VA Medical Center, and Associate Professor of Medicine in the Indiana University School of Medicine. His area of focus is cancer health services research and his research activities are based in the IU Center for Health Services and Outcomes Research, the VA Health Services Research and Development Center for Health Information and Communication, and Regenstrief Institute's William M. Tierney Center for Health Services Research. Dr. Haggstrom is broadly interested in the measurement and improvement of the quality of health care delivery across the cancer continuum. In addition to implementation science, his research interests specifically include personal health records, patient-physician communication, and risk perception.
Dr. Haggstrom has strong interest in applied medical informatics, including health information exchange. As a former Robert Wood Johnson Foundation Physician Faculty Scholar (2009-2012), he studied the identification of patient, physician, and organizational factors associated with the underuse and overuse of surveillance care. He has also developed a personal health record tool to meet the patient-centered needs of survivors and has performed qualitative and quantitative evaluation of that tool. Dr. Haggstrom directs the IUPUI Center for Cancer Population Analytics and Patient-Centered Informatics and is Co-Director of the Cancer Prevention and Control Program at Simon Cancer Center.
Dr. Haggstrom is board certified in Internal Medicine and a staff physician at Richard L. Roudebush VA Medical Center.
HOSPITALS & AFFILIATIONS
|Richard L. Roudebush VA Medical Center|
|School of Medicine||University of Nebraska School of Medicine|
|Residency||Dartmouth-Hitchcock Medical Center|
|Residency||Medical College of Wisconsin|
|Fellowship||University of California|
|Fellowship||National Cancer Institute|
I. IUPUI Signature Center Program (2013-2016)
“Center for Cancer Population Analytics and Patient-Center Informatics”
Program aims to (1) build collaborative, multidisciplinary scientific teams to create national leaders in the state of Indiana in the fields of cancer health services research and informatics and (2) perform top-tier national cancer health services research and “big data” analytics to improve the quality, efficiency, coordination, and outcomes of cancer care.
II. Merck/Regenstrief Program in Personalized Health Care Research and Innovation (2013-2015)
“Patient-Reported Outcomes Capture Platform (ePRO)” (Project Leader)
Project to create a flexible, scalable, and generalizable electronic platform for generating and storing Patient-Reported Outcomes (PROs) on a variety of topics including medication, adherence, patient-reported quality, and patient-reported symptoms.
III. Merck/Regenstrief Program in Personalized Health Care Research and Innovation (2014-2015)
“Melanoma Phenotype Algorithm Development and Validation Using INPC Data” (co-PI)
Measuring the predictive value and sensitivity of Natural Language processing (NLP) technology in conjunction with EMR, in identifying melanoma cases, with medical chart review and the tumor registry as a gold standards.
IV. National Cancer Institute (2014-2016)
“Explaining Variations in End-of-Life Care Intensity” (Site PI)
Study based at Harvard Medical School (Keating, PI) to understand the relative contribution of patient, physician, and area-level factors in explaining variations in intensity of end of life care.
V. IU Simon Cancer Center (2013-2015)
"Population-Based, Guideline-Concordant Surveillance Among Cancer Survivors." (PI)
Project to describe state of Indiana population-based patterns of underuse and overuse of surveillance tests among cancer survivors after primary treatment and to test the association of social determinants with receipt of surveillance.
IV. VA HSR&D Merit Review Award (2012-2015)
"Evaluation of VLER-Indiana Health Information Exchange (IHIE) Demonstration" (PI)
Aims are to study the effect of the VA-IHIE demonstration project upon the quality and cost of care among Veterans. Quality will be measured in terms of ambulatory care performance measures likely sensitive to HIE, as well as potential overuse, representative of unnecessary repeated, redundant testing.
|Selected Publications|||||Go To PubMed List >>|
1. Partin MR, Gravely AA, Burgess JF Jr, Haggstrom DA, Lillie SE, Nelson DB, Nugent SM, Shaukat A, Sultan S, Walter LC, Burgess DJ. Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results. Cancer. 2017 May 11. doi: 10.1002/cncr.30765. [Epub ahead of print] PubMed PMID: 28493543.
2. Nguyen KA, Haggstrom DA, Ofner S, Perkins SM, French DD, Myers LJ, Rosenman M, Weiner M, Dixon BE, Zillich AJ. Medication Use among Veterans across Health Care Systems. Appl Clin Inform. 2017 Mar 8;8(1):235-249. doi:10.4338/ACI-2016-10-RA-0184. PubMed PMID: 28271121; PubMed Central PMCID:PMC5373767.
3. Sehdev A, Sherer EA, Hui SL, Wu J, Haggstrom DA. Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities. Cancer. 2017 Jun 15;123(12):2338-2351. doi:10.1002/cncr.30569. Epub 2017 Feb 17. PubMed PMID: 28211937.
4. Gray SW, Kim B, Sholl L, Cronin A, Parikh AR, Klabunde CN, Kahn KL, Haggstrom DA, Keating NL. Medical Oncologists' Experiences in Using Genomic Testing forLung and Colorectal Cancer Care. J Oncol Pract. 2017 Mar;13(3):e185-e196. doi:10.1200/JOP.2016.016659. Epub 2017 Jan 17. PubMed PMID: 28095174; PubMed Central PMCID: PMC5456256.
5. Bernat JK, Skolarus TA, Hawley ST, Haggstrom DA, Darwish-Yassine M, Wittmann DA. Negative information-seeking experiences of long-term prostate cancer survivors. J Cancer Surviv. 2016 Dec;10(6):1089-1095. Epub 2016 May 26. PubMedPMID: 27229868; PubMed Central PMCID: PMC5097017.
6. Parikh AR, Keating NL, Liu PH, Gray SW, Klabunde CN, Kahn KL, Haggstrom DA, Syngal S, Kim B. Oncologists' Selection of Genetic and Molecular Testing in the Evolving Landscape of Stage II Colorectal Cancer. J Oncol Pract. 2016Mar;12(3):e308-19, 259-60. doi: 10.1200/JOP.2015.007062. PubMed PMID: 26962170;PubMed Central PMCID: PMC4960467.
7. Sherer EA, Fisher DA, Barnd J, Jackson GL, Provenzale D, Haggstrom DA. The accuracy and completeness for receipt of colorectal cancer care using Veterans Health Administration administrative data. BMC Health Serv Res. 2016 Feb11;16:50. doi: 10.1186/s12913-016-1294-9. PubMed PMID: 26869265; PubMed Central PMCID: PMC4751682.
8. Keating NL, Landrum MB, Huskamp HA, Kouri EM, Prigerson HG, Schrag D, Maciejewski PK, Hornbrook MC, Haggstrom DA. Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients? Health Serv Res. 2016Aug;51(4):1584-94. doi: 10.1111/1475-6773.12440. Epub 2016 Jan 22. PubMed PMID:26799913; PubMed Central PMCID: PMC4946029.
9. French DD, Dixon BE, Perkins SM, Myers LJ, Weiner M, Zillich AJ, Haggstrom DA. Short-Term Medical Costs of a VHA Health Information Exchange: A CHEERS-Compliant Article. Medicine (Baltimore). 2016 Jan;95(2):e2481. doi:10.1097/MD.0000000000002481. PubMed PMID: 26765453; PubMed Central PMCID:PMC4718279.
10. Bernat JK, Wittman DA, Hawley ST, Hamstra DA, Helfand AM, Haggstrom DA, Darwish-Yassine M, Skolarus TA. Symptom burden and information needs in prostate cancer survivors: a case for tailored long-term survivorship care. BJU Int. 2016 Sep;118(3):372-8. doi: 10.1111/bju.13329. Epub 2015 Oct 26. PubMed PMID: 26389529; PubMed Central PMCID: PMC4835263.